SANDOZ

SANDOZ CA + VITAMINA C 1000MG X 10 COMPRIMATE EFERVESCENTE

You're reading an Auto-translation.

Composition. One effervescent tablet contains calcium 0.26 g as calcium carbonate 0.327 g and calcium gluconolactate 1 g, and ascorbic acid 1 g.

Therapeutic indications.

Calcium and vitamin C deficiency.

Increased need for calcium and vitamin C (e.g., during pregnancy and lactation, in children during periods of rapid growth, in the elderly, during infectious diseases and convalescence).

Adjuvant in colds and flu.

Dosage and administration.

Effervescent tablets should be dissolved in a glass of water.

Adults and children over 7 years: the recommended dose is 1 Calciu-Sandoz + Vit. C 1000 mg effervescent tablet per day.

Children: - children aged 3 - 7 years: the recommended dose is 1/2 Calciu-Sandoz + Vit. C 1000 mg effervescent tablet per day.

Administration to children under 3 years is not recommended; age-appropriate pharmaceutical forms should be used.

Precautions.

For patients with mild hypercalciuria (exceeding 300 mg - 7.5 mmol/24 hours), with moderate or mild renal insufficiency, monitoring of urinary calcium excretion is necessary. If necessary, the calcium dose should be reduced or treatment should be discontinued.

Patients predisposed to kidney stone formation are advised to increase fluid intake.

During calcium treatment, high doses of vitamin D and derivatives should be avoided, unless specifically recommended and performed under strict medical supervision.

Since citrates have been reported to increase aluminum absorption, Calciu-Sandoz + Vit. C 1000 mg effervescent tablets, which contain citric acid as an excipient, should be used with caution in patients with severe renal insufficiency, especially those receiving aluminum-based medications.

Diabetic patients should consider the sugar content of Calciu-Sandoz + Vit. C 1000 mg (2 g/effervescent tablet), and patients requiring a low-sodium diet should consider the sodium content of Calciu-Sandoz + Vit. C 1000 mg (0.27 g/effervescent tablet).

High doses of ascorbic acid may interfere with certain methods for determining urinary glucose.

Special warnings.

Pregnancy and lactation

Epidemiological studies with calcium administration have shown that it does not increase the teratogenic risk to the fetus. Although additional calcium may be excreted in breast milk, the concentration is not sufficient to produce adverse reactions in the newborn.

Effects on ability to drive and use machines

The medicine is not expected to affect the ability to drive or use machines.

Packaging. Box with a polypropylene tube containing 10 effervescent tablets

Page updated on: 09.06.2021